Rationale for modifying neck dissection

Journal of Surgical Oncology

Volumn 97, Issue 8, 2008, Pages 674-682

  Givi, Babak ^a   Andersen, Peter E ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Neck dissection; Surgical treatment of head and neck cancers; Trends in neck dissection

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CERVICAL LYMPH NODE; CERVICOBRACHIAL NEURALGIA; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CRANIOFACIAL MORPHOLOGY; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; LARYNX CANCER; LYMPH FLOW; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MORBIDITY; MOUTH CANCER; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; NECK METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX TUMOR; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; TONGUE CANCER; TUMOR LOCALIZATION;

HEAD AND NECK NEOPLASMS; HUMANS; LYMPH; LYMPH NODES; LYMPHATIC VESSELS; NECK DISSECTION; RHEOLOGY;

EID: 44949151160     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21016     Document Type: Review

References (95)

1. Butlin HTSB, Spencer WG: Diseases of the Tongue, etc. [With a bibliography.]. pp. xii. 475. London: Cassell & Co.; 1900.
2. Solis-Cohen J: The surgical treatment of laryngeal cancer. Trans Am Laryngol Assoc 1901;22:75-87.
3. Crile GW: On the surgical treatemnt of cancer of the head and neck. With a summary of one hundred and twenty-one operations performed upon one hundred and five patients. Trans South Surg Gynecol Assoc 1905;18:108-127.
4. Crile GW: Excision of cancer of the head and neck. With special reference to the plan of dissection based on one hundred and thirty-two operations. J Am Med Assoc 1906;47:1780-1786.
5. Martin H: The treatment of cervical metastatic cancer. Ann Surg 1941;114:972-985.
6. Martin H, Del Valle B, Ehrlich H, et al.: Neck dissection. Cancer 1951;4:441-499.
7. Robbins KT, Medina JE, Wolfe GT, et al.: Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 1991;117:601-605.
8. Robbins KT, Clayman G, Levine PA, et al.: Neck dissection classification update: Revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002; 128:751-758.
9. Fisch UP: Cervical lymphography in cases of laryngo-pharyngeal carcinoma. J Laryngol Otol 1964;78:715-726.
10. Fisch UP, Sigel ME: Cervical lymphatic system as visualized by lymphography. Ann Otol Rhinol Laryngol 1964;73:870-882.
11. Nahum AM, Mullally W, Marmor L: A syndrome resulting from radical neck dissection. Arch Otolaryngol 1961;74:424-428.
12. Suarez O: El problema de las metastasis linfaticas y alejadas del cancer de laringe e hipofaringe. Rev Otorrinolaringol 1963;23: 804-808.
13. Som PM: Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol 1992;158:961-969.
14. Giron J, Chisin R, Paul JL, et al.: Multimodality imaging of cervical adenopathies. Eur J Radiol 1996;21:159-166.
15. Nakamura T, Sumi M: Nodal imaging in the neck: Recent advances in US, CT and MR imaging of metastatic nodes. Eur Radiol 2007;17:1235-1241.
16. Brkovich VS, Miller FR, Karnad AB, et al.: The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 2006;116:855-858.
17. Shah JP: Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg 1990;160:405-409.
18. Byers RM, Wolf PF, Ballantyne AJ: Rationale for elective modified neck dissection. Head Neck Surg 1988;10:160-167.
19. Pitman KT, Johnson JT, Myers EN: Effectiveness of selective neck dissection for management of the clinically negative neck. Arch Otolaryngol Head Neck Surg 1997;123:917-922.
20. Lindberg R: Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972;29:1446-1449.
21. Spiro RH, Huvos AG, Wong GY, et al.: Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 1986;152:345-350.
22. Weiss MH, Harrison LB, Isaacs RS: Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 1994;120:699-702.
23. Pitman KT: Rationale for elective neck dissection. Am J Otolaryngol 2000;21:31-37.
24. Byers RM, El-Naggar AK, Lee YY, et al.: Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck 1998;20: 138-144.
25. Fakih AR, Rao RS, Borges AM, et al.: Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg 1989;158:309-313.
26. Vandenbrouck C, Sancho-Garnier H, Chassagne D, et al.: Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity: Results of a randomized clinical trial. Cancer 1980;46:386-390.
27. Kligerman J, Lima RA, Soares JR, et al.: Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg 1994;168:391-394.
28. Haddadin KJ, Soutar DS, Oliver RJ, et al.: Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999;21:517-525.
29. Yuen AP, Wei WI, Wong YM, et al.: Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck 1997;19:583-588.
30. Capote A, Escorial V, Munoz-Guerra MF, et al.: Elective neck dissection in early-stage oral squamous cell carcinoma - Does it influence recurrence and survival? Head Neck 2007;29:3-11.
31. Dias FL, Kligerman J, Matos de Sa G, et al.: Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 2001;125:23-29.
32. Duvvuri U, Simental AA, Jr, D'Angelo G, et al.: Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope 2004;114:2228-2234.
33. Keski-Santti H, Atula T, Tornwall J, et al.: Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol 2006;42:96-101.
34. Kligerman J, Olivatto LO, Lima RA, et al.: Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx. Am J Surg 1995;170:436-439.
35. Andersen PE, Cambronero E, Shaha AR, et al.: The extent of neck disease after regional failure during observation of the N0 neck. Am J Surg 1996;172:689-691.
36. Layland MK, Sessions DG, Lenox J: The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 2005;115:629-639.
37. Khafif RA, Gelbfish GA, Tepper P, et al.: Elective radical neck dissection in epidermoid cancer of the head and neck. A retrospective analysis of 853 cases of mouth, pharynx, and larynx cancer. Cancer 1991;67:67-71.
38. Candela FC, Kothari K, Shah JP: Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck 1990;12:197-203.
39. Candela FC, Shah J, Jaques DP, et al.: Patterns of cervical node metastases from squamous carcinoma of the larynx. Arch Otolaryngol Head Neck Surg 1990;116:432-435.
40. Shah JP, Candela FC, Poddar AK: The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 1990;66:109-113.
41. Brazilian Head and Neck Cancer Study Group: Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Am J Surg 1998;176:422-427.
42. Brazilian Head and Neck Cancer Study Group: End results of a prospective trial on elective lateral neck dissection vs type III modified radical neck dissection in the management of supraglottic and transglottic carcinomas. Head Neck 1999;21:694-702.
43. Ambrosch P, Kron M, Pradier O, et al.: Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001;124:180-187.
44. Chepeha DB, Hoff PT, Taylor RJ, et al.: Selective neck dissection for the treatment of neck metastasis from squamous cell carcinoma of the head and neck. Laryngoscope 2002;112:434-438.
45. Johnson JT: Carcinoma of the larynx: Selective approach to the management of cervical lymphatics. Ear Nose Throat J 1994; 73:303-305.
46. Medina JE, Byers RM: Supraomohyoid neck dissection: Rationale, indications, and surgical technique. Head Neck 1989;11:111-122.
47. Muzaffar K: Therapeutic selective neck dissection: A 25-year review. Laryngoscope 2003;113:1460-1465.
48. Spiro RH, Morgan GJ, Strong EW, et al.: Supraomohyoid neck dissection. Am J Surg 1996;172:650-653.
49. Ferlito A, Rinaldo A, Silver CE, et al.: Elective and therapeutic selective neck dissection. Oral Oncol 2006;42:14-25.
50. Kowalski LP, Carvalho AL: Feasibility of supraomohyoid neck dissection in N1 and N2a oral cancer patients. Head Neck 2002; 24:921-924.
51. Conley J: Radical neck dissection. Laryngoscope 1975;85:1344-1352.
52. Bocca E, Pignataro O: A conservation technique in radical neck dissection. Ann Otol Rhinol Laryngol 1967;76:975-987.
53. Bocca E: Supraglottic laryngectomy and functional neck dissection. J Laryngol Otol 1966;80:831-838.
54. Bocca E: Critical analysis of the techniques and value of neck dissection. Nuovo Arch Ital Otol Rhinol Laringol 1976;4:151-158.
55. Bocca E, Pignataro O, Sasaki CT: Functional neck dissection. A description of operative technique. Arch Otolaryngol 1980;106: 524-527.
56. Bocca E, Pignataro O, Oldini C, et al.: Functional neck dissection: An evaluation and review of 843 cases. Laryngoscope 1984; 94:942-945.
57. Bocca E: Sixteenth Daniel C. Baker, Jr, memorial lecture. Surgical management of supraglottic cancer and its lymph node metastases in a conservative perspective. Ann Otol Rhinol Laryngol 1991;100:261-267.
58. Andersen PE, Shah JP, Cambronero E, et al.: The role of comprehensive neck dissection with preservation of the spinal accessory nerve in the clinically positive neck. Am J Surg 1994; 168:499-502.
59. Byers RM: Modified neck dissection. A study of 967 cases from 1970 to 1980. Am J Surg 1985;150:414-421.
60. Pontes E, Filho JG, Agra IM, et al.: Internal jugular vein preservation in neck dissection for pN1-N2c oral and oropharyngeal carcinoma. Am J Otolaryngol 2007;28:316-320.
61. Buckley JG, Feber T: Surgical treatment of cervical node metastases from squamous carcinoma of the upper aerodigestive tract: Evaluation of the evidence for modifications of neck dissection. Head Neck 2001;23:907-915.
62. Traynor SJ, Cohen JI, Gray J, et al.: Selective neck dissection and the management of the node-positive neck. Am J Surg 1996; 172:654-657.
63. Pellitteri PK, Robbins KT, Neuman T: Expanded application of selective neck dissection with regard to nodal status. Head Neck 1997;19:260-265.
64. Andersen PE, Warren F, Spiro J, et al.: Results of selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg 2002;128:1180-1184.
65. Leemans CR, Snow GB: Is selective neck dissection really as efficacious as modified radical neck dissection for elective treatment of the clinically negative neck in patients with squamous cell carcinoma of the upper respiratory and digestive tracts? Arch Otolaryngol Head Neck Surg 1998;124:1042-1044.
66. McHam SA, Adelstein DJ, Rybicki LA, et al.: Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;25:791-798.
67. Peters LJ, Weber RS, Morrison WH, et al.: Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 1996;18:552-559.
68. Velazquez RA, McGuff HS, Sycamore D, et al.: The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2004;130:74-77.
69. Ojiri H, Mendenhall WM, Stringer SP, et al.: Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2002;52: 420-428.
70. Lowe VJ, Dunphy FR, Varvares M, et al.: Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck 1997;19:666-674.
71. Kubota K, Yokoyama J, Yamaguchi K, et al.: FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: Comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004;31:590-595.
72. Ware RE, Matthews JP, Hicks RJ, et al.: Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck. Head Neck 2004; 26:1008-1017.
73. Wong RJ, Lin DT, Schoder H, et al.: Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199-4208.
74. Gourin CG, Williams HT, Seabolt WN, et al.: Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 2006;116:705-710.
75. Newman JP, Terris DJ, Pinto HA, et al.: Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer. Ann Otol Rhinol Laryngol 1997;106:117-122.
76. Davidson BJ, Newkirk KA, Harter KW, et al.: Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 1999;125:401-405.
77. Lavertu P, Bonafede JP, Adelstein DJ, et al.: Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:401-406.
78. Sassier AM, Esclamado RM, Wolf GT: Surgery after organ preservation therapy. Analysis of wound complications. Arch Otolaryngol Head Neck Surg 1995;121:162-165.
79. Ferlito A, Shaha AR, Silver CE, et al.: Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001;63:202-207.
80. Kowalski LP: Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg 2002;128: 58-62.
81. Merino OR, Lindberg RD, Fletcher GH: An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1977;40:145-151.
82. Barkley HT, Jr, Fletcher GH, Jesse RH, et al.: Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg 1972;124:462-467.
83. Armstrong J, Pfister D, Strong E, et al.: The management of the clinically positive neck as part of a larynx preservation approach. Int J Radiat Oncol Biol Phys 1993;26:759-765.
84. Kutler DI, Patel SG, Shah JP: The role of neck dissection following definitive chemoradiation. Oncology (Williston Park) 2004;18:993-998; discussion 999, 1003-1004, 1007.
85. Pellitteri PK, Ferlito A, Rinaldo A, et al.: Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: Is it necessary for all? Head Neck 2006;28:166-175.
86. Wolf GT, Fisher SG: Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 1992; 102:934-939.
87. Brizel DM, Prosnitz RG, Hunter S, et al.: Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;58:1418-1423.
88. Argiris A, Stenson KM, Brockstein BE, et al.: Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447-455.
89. dayman GL, Johnson CJ II, Morrison W, et al.: The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 2001; 127:135-139.
90. Corry J, Rischin D, Smith JG, et al.: Radiation with concurrent late chemotherapy intensification ('chemoboost') for locally advanced head and neck cancer. Radiother Oncol 2000;54:123-127.
91. Garden AS, Glisson BS, Ang KK, et al.: Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: Toxicities and responses. J Clin Oncol 1999;17:2390-2395.
92. Koch WM, Lee DJ, Eisele DW, et al.: Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1995:121:974-980.
93. Robbins KT, Wong FS, Kumar P, et al.: Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999:125:670-675.
94. Grabenbauer GG, Rodel C, Ernst-Stecken A, et al.: Neck dissection following radiochemotherapy of advanced head and neck cancer - For selected cases only? Radiother Oncol 2003; 66:57-63.
95. Stenson KM, Haraf DJ, Pelzer H, et al.: The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: The feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000;126:950-956.